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Resistance to anthelmintic drugs is a major problem in the global fight against parasitic
nematodes infecting humans and animals. While previous studies have identified
mutations in drug target genes in resistant parasites, changes in the expression levels
of both targets and transporters have also been reported. The mechanisms underlying
these changes in gene expression are unresolved. Here, we take a novel approach to
this problem by investigating the role of small regulatory RNAs in drug resistant strains of
the important parasite Haemonchus contortus. microRNAs (miRNAs) are small (22 nt)
non-coding RNAs that regulate gene expression by binding predominantly to the 3′
UTR of mRNAs. Changes in miRNA expression have been implicated in drug resistance
in a variety of tumor cells. In this study, we focused on two geographically distinct
ivermectin resistant strains of H. contortus and two lines generated by multiple rounds
of backcrossing between susceptible and resistant parents, with ivermectin selection.
All four resistant strains showed significantly increased expression of a single miRNA,
hco-miR-9551, compared to the susceptible strain. This samemiRNA is also upregulated
in a multi-drug-resistant strain of the related nematode Teladorsagia circumcincta.
hco-miR-9551 is enriched in female worms, is likely to be located on the X chromosome
and is restricted to clade V parasitic nematodes. Genes containing predicted binding
sites for hco-miR-9551 were identified computationally and refined based on differential
expression in a transcriptomic dataset prepared from the same drug resistant and
susceptible strains. This analysis identified three putative target mRNAs, one of which,
a CHAC domain containing protein, is located in a region of the H. contortus genome
introgressed from the resistant parent. hco-miR-9551 was shown to interact with the 3′
UTR of this gene by dual luciferase assay. This study is the first to suggest a role for
miRNAs and the genes they regulate in drug resistant parasitic nematodes. miR-9551
also has potential as a biomarker of resistance in different nematode species.
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INTRODUCTION
Just as antimicrobial resistance poses a serious threat to the
treatment of bacterial infections, anthelmintic resistance is a
major challenge for the control of parasitic nematodes. This
is particularly so in the livestock industry, with nematodes of
small ruminants showing resistance to multiple anthelmintics
(Kaplan and Vidyashankar, 2012). Three classes of drug are in
common use in livestock species; the benzimidazole compounds,
the cholinergic compounds (e.g., levamisole) and themacrocyclic
lactones [e.g., ivermectin (IVM)]. In some parts of the world,
including the United Kingdom, parasites resistant to all three
drug classes have been identified (Sargison et al., 2007), posing
a threat to the viability of livestock farming and compromising
global food security. Of these broad-spectrum compounds, the
macrocyclic lactones are the most recent and the most widely
used. IVM was introduced to the animal health market in
1981 and within seven years, the first reports of resistance
were recorded from South Africa (van Wyk and Malan,
1988). Since then, many studies have sought to determine
the molecular mechanisms of IVM resistance. In the model
nematode Caenorhabditis elegans, IVM targets the glutamate-
gated chloride channels (GluCls) (Cully et al., 1994) causing
paralysis of both the pharyngeal and body wall muscle in sensitive
worms (Pemberton et al., 2001). High-level resistance to IVM in
C. elegans is multigenic (Dent et al., 2000), requiring mutations
in three separate genes encoding sub-units of the GluCls (avr-
14, avr-15, and glc-1). While other genes have been implicated
in IVM resistance in C. elegans, most of these modulate the
resistance phenotype and are unable on their own to confer high-
level resistance. Whether or not similar mechanisms underlie
IVM resistance in parasitic nematodes is the focus of much
debate (Gilleard and Beech, 2007).
Recent studies on the important livestock parasite
Haemonchus contortus have implicated single nucleotide
polymorphisms (SNPs) and other mutations in orthologs of
genes known to be involved in IVM resistance in C. elegans
(McCavera et al., 2009), but there is no consistent clear-cut
association between the presence of particular SNPs and
IVM resistance in different isolates. The situation is further
complicated by known differences in the targets of IVM in
C. elegans and H. contortus. For example, glc-1 is not present in
the H. contortus genome, while the parasitic species expresses
two additional GluCl sub-units, glc-5 and glc-6, that are absent
from C. elegans (Laing et al., 2013). IVM is also employed in mass
drug administration campaigns for control of filarial infections,
such as Onchocerca volvulus in humans (Osei-Atweneboana
et al., 2011) and Dirofilaria immitis in dogs. In both these
parasites, resistance is a growing concern (Bourguinat et al.,
2015; Wolstenholme et al., 2015; Doyle et al., 2017).
In addition to SNPs, differences have been identified in the
levels of expression of GluCls in IVM resistant worms (El-
Abdellati et al., 2011) and in various subunits of levamisole-
sensitive acetylcholine receptors (Kopp et al., 2009), in addition
to P-glycoproteins and ABC drug transporters (Dicker et al.,
2011; Raza et al., 2016), suggesting that changes in the
composition of drug-sensitive channels and drug efflux pathways
may be involved in resistance. The mechanisms responsible for
such changes in gene expression are largely unexplored, although
deletions/polymorphisms in gene regulatory regions (such as the
3′ untranslated region, 3′ UTR) have been reported (Rao et al.,
2009; Neveu et al., 2010). In this paper, we adopt a novel approach
to understanding anthelmintic resistance by investigating the
profile of miRNAs in drug resistant and susceptible isolates of
H. contortus.miRNAs are a class of small non-coding RNAs with
important roles in regulating gene expression (Filipowicz and
Sonenberg, 2015). First identified in C. elegans (Lee et al., 1993),
they are present in animals, plants and viruses with roles in many
fundamental aspects of development, as well as in diseases such
as cancer (Adams et al., 2014). miRNAs exert their function by
binding to complementary sequences most often in the 3′ UTR
of the target genes, in the context of the RNA Induced Silencing
Complex (RISC). miRNAs have been intensively studied in
tumor cells where their expression is frequently dysregulated.
Consequently they have been proposed as targets for novel
chemotherapy as well as diagnostic biomarkers (Suzuki et al.,
2015). miRNAs have also been implicated in drug resistance in
a variety of tumor models, where they can act by modulating the
abundance of drug metabolizing enzymes or drug transporters,
permitting a more efficient efflux of drug in resistant cells, or by
modulating various signaling pathways (To, 2013).
We recently described the miRNAs of H. contortus adult and
infective L3 stages using a deep sequencing and bioinformatic
approach, resulting in the identification of 192 miRNAs (Winter
et al., 2012). Here, we build upon these observations to investigate
miRNA expression in strains of H. contortus that are resistant
or susceptible to IVM. These included the drug susceptible
MHco3(ISE) strain and two IVM-resistant strains of different
geographical origin, MHco4(WRS) from South Africa and
MHco10(CAVR) from Australia. Additionally, we had access to
a unique resource, two hybrid lines resulting from a series of
backcrosses between the IVM susceptible parent and each of the
IVM-resistant strains (Redman et al., 2012). These backcrossed
worms display a genotype more similar to the susceptible parent,
while exhibiting IVM resistance, indicative of introgression of
resistance alleles into the susceptible background. We show
that the level of a single miRNA is significantly up-regulated
in parental and backcrossed resistant strains compared to the
susceptible MHco3(ISE) and identify possible target mRNAs of
this miRNA, the expression levels of which correlate inversely
with miRNA levels. Moreover, the orthologous miRNA is present
at increased levels in a multidrug resistant strain of the related
nematode Teladorsagia circumcincta (MTci5) relative to an
anthelmintic susceptible strain (MTci2). Our results suggest
a novel paradigm to help explain the development of IVM
resistance in parasitic nematodes.
MATERIALS AND METHODS
Ethics Statement
Experimental infections were performed at the Moredun
Research Institute, UK as described previously (Laing et al.,
2013). All experimental procedures were examined and approved
by the Moredun Research Institute Experiments and Ethics
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Committee (MRI E46 11) and were conducted under approved
UK Home Office license (PPL 60/03899) in accordance with the
1986 Animals (Scientific Procedures) Act.
Worm Strains and Backcrosses
The MHco3(ISE) strain is susceptible to all broad-spectrum
anthelmintics (Roos et al., 2004) and was inbred to produce
the material for the H. contortus genome sequencing project
at the Wellcome Trust Sanger Institute (Laing et al., 2013).
MHco4(WRS) originates from South Africa and is resistant to
IVM and benzimidazole anthelmintics (van Wyk and Malan,
1988) and is also known as the White River Strain, while
MHco10(CAVR) is an Australian strain otherwise known as
the Chiswick AVermectin Resistant strain (Le Jambre et al.,
1995) which is highly resistant to IVM but susceptible to
benzimidazoles and levamisole. All strains were maintained
at the Moredun Research Institute. Introgression of IVM
resistance-conferring loci from both resistant strains into the
genetic background of the susceptible strain MHco3(ISE) was
carried out as described previously by Redman et al. (2012).
In short, progeny from the crosses of the resistant strains
with MHco3(ISE) underwent four rounds of back-crossing
to MHco3(ISE), with IVM selection, to produce a fourth
backcross generation: MHco3/4.BC4 [MHco3(ISE) crossed with
MHco4(WRS)] and MHco3/10.BC4 [MHco3(ISE) crossed with
MHco10(CAVR)]. In this manuscript the backcrossed strains
are referred to as MHco3/4.BC4 and MHco3/10.BC4. For
T. circumcincta, two strains were compared: a susceptible strain
(MTci2) originally from Weybridge, that was isolated prior
to the use of broad spectrum anthelmintics and a multi-
drug resistant strain, MTci5, that shows decreased susceptibility
to fenbendazole, levamisole, and IVM (Dicker et al., 2011).
Female worms of these strains were available as frozen pellets
from MRI.
Re-establishment of MHco3/4.BC4 and
MHco3/10.BC4
For this study,MHco3/4.BC4 andMHco3/10.BC4 were used after
an additional three rounds of selection with IVM (OramecTM)
at 0.2 mg/Kg, with one exception. To re-establish MHco3/4.BC4
and MHco3/10.BC4, sheep were infected with 5,000 L3 of
the appropriate line and treated with IVM at either 0.1 or
0.2 mg/Kg. At the first passage, no L3 were obtained from
fecal cultures from the sheep infected with MHco3/10 BC4
treated at 0.2 mg/Kg IVM. Consequently, for the next round
of selection, the input L3 came from the animal treated
with IVM at 0.1 mg/Kg. The origin and maintenance of
MHco3/4.BC4 and MHco3/10.BC4 is described in data shown
in Table S1.
Preparation of Samples for Microarray
Analysis
Three sheep were infected per os with 5,000 L3 of each
of the strains, MHco3(ISE), MHco4(WRS), MHco10(CAVR),
MHco3/4.BC4, and MHco3/10.BC4 and were not drug treated.
An additional three sheep per strain were infected with
only the IVM-resistant strains MHco4(WRS), MHco10(CAVR),
MHco3/4.BC4, and MHco3/10.BC4 and treated with IVM at 0.2
mg/Kg 7 days prior to euthanasia. Infected sheep were euthanized
at 28 days post-infection. Surviving worms were isolated from
the abomasum, washed extensively in PBS and picked into
groups of 20 males or 20 female worms and immediately snap
frozen in liquid nitrogen. RNA was prepared from each sample
individually by grinding the pellet using a liquid nitrogen-
cooled pestle and mortar and standard Trizol R© protocol
(Invitrogen). RNA quality and quantity was assessed using a
spectrophotometer and Bioanalyzer (Agilent 2100 Bioanalyzer).
7.5µg of male RNA and 7.5µg of female worm RNA from paired
samples (i.e., from the same sheep) was pooled and sent on dry
ice to LC Sciences (Houston, Texas) for microarray. The arrays
contained 609 predicted miRNA sequences from H. contortus
(Winter et al., 2012), 369 sequences from C. elegans miRNAs
(miRBase 16) and 50 control sequences. The array was probed
with triplicate biological samples of pooled male and female RNA
labeled with Cy5. miRNA expression was analyzed in different
worm groups using twomethods, ANOVA (Analysis of Variance)
and t-test, and the degree of significance evaluated by comparing
between-group variation with within-group variation. For an
experiment involving more than two sample groups, ANOVA
was first applied to produce a miRNA expression profile overview
across all samples, then t-tests were performed to identify
significantly differentiated miRNAs among all combinations of
two groups.
Life Cycle Microarray
To ascertain the expression profile of hco-miR-9551 throughout
the H. contortus life cycle, data from a different microarray
experiment were analyzed. This array contained exactly the same
sequences as described above but the samples used to probe the
array were all isolated fromMHco3(ISE) worms, as follows: adult
male, adult female, L4 isolated at day 7 post-infection, L3, in vitro
activated L3 (exsheathed and cultured for 24 h in RPMI-1640 at
37◦C and 5% CO2 in air) and gut-enriched tissue (dissected from
adult female worms). Biological triplicates of RNA were prepared
for each sample as described previously, but in this experiment
RNA was labeled with Cy3.
The microarray dataset supporting the expression of miRNAs
in resistant vs. susceptible H. contortus can be found on NCBI
GEO (https://www.ncbi.nlm.nih.gov/geo/): Series GSE79542.
Themicroarray dataset showing the expression ofmiRNAs across
the H. contorus life cycle can be found at (https://www.ncbi.nlm.
nih.gov/geo/): Series GSE101501.
qRT-PCR
For qRT-PCR analyses, 1 µg of DNase I R©-treated (Ambion)
total RNA from female, male worms or L3 was used in
polyadenylation and reverse transcription reactions (plus and
minus enzyme) using the miRNA 1stStrand cDNA Synthesis R©
protocol (Agilent Technologies). Single RNA samples were
also processed for qRT-PCR from female MHco3(ISE) worm
gut tissue, from in vitro released eggs/L1 of MHco3 (ISE)
worms or from parasite excretory-secretory (ES) products
from MHco3/4.BC4 and MHco3/10.BC4 worms. qPCR was
carried out following the miRNA qPCR Master Mix R© protocol
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 November 2017 | Volume 7 | Article 452
Gillan et al. miRNA and Drug Resistance in Nematodes
(Agilent Technologies) and results analyzed using MxPro qPCR
Software, Version 4.10. Results were normalized to hco-miR-
50, which was found by microarray to be present at similar
levels throughout all the experimental conditions examined.
The sequences of the HPLC-purified oligonucleotide primers
(Eurofins) are as follows: hco-miR-50–5′-TGATATGTCTGG
TATTCTTGG-3′; hco-miR-9551–5′-CACAGCATTTTACTGAG
CC-3′. Agilent Universal ReversemiRNAprimer R© was used in all
reactions.
Unless stated otherwise, qRT-PCR was performed on three
biological samples and each PCR was carried out in triplicate.
Lin-Reg R© software (Ramakers et al., 2003; Ruijter et al., 2009)
was used to calculate PCR efficiency using linear regression.
These data were then processed by REST2009 R© software
(qiagen.com) (Pfaffl, 2001; Pfaffl et al., 2002), which uses a
mathematic model to account for any differences in PCR
efficiencies between normaliser genes and genes of interest
(http://rest.gene-quantification.info). This allows compensation
for variations in starting material thus providing more accurate
quantification of gene expression.
Bioinformatic Prediction of mRNA Targets
and Pathway Analysis
For this analysis two in silico 3′ UTR libraries were combined to
generate a single searchable database. The first library contained
3′ UTR sequences predicted from theH. contortus transcriptomic
data (Laing et al., 2013). This library contained 14,507 predicted
3′ UTRs from 11,264 genes and thus represented only ∼52% of
the genome (n= 21,799). The predicted 3′ UTRs ranged in length
from 1–15,355 nt, although the majority were between 100 and
1,100 nt. 3′ UTRs of 50–1,000 nt were selected (11,328 sequences
representing 8,992 genes) and combined with data from a second
library that contained 1 kb of downstream sequence from each
predicted gene in the genome, or sequence up to the end of
a scaffold. As it was based on transcriptomic data, the first 3′
UTR database was considered the more reliable and sequences
from the downstream database were used to “fill in” the missing
3′ UTRs.
The combined library, representing 3′ UTRs of 93% of all
predicted H. contortus genes, was screened using the following
online miRNA target prediction algorithms: PITA (Kertesz
et al., 2007) (with default settings: seed sequence of 8 bases,
ddG<−103), miRANDA (Enright et al., 2003) (filtered for
scores >145 and energies<−10), and RNAhybrid (Rehmsmeier
et al., 2004) (p < 0.1 and energies <−22). Only 3′ UTRs
that scored positive with all three programmes were retained.
These were further analyzed to ensure that the binding sites
predicted by each programme overlapped, resulting in a set of
“high confidence” target mRNAs. These transcripts were then
assessed using previously created RNAseq datasets generated
from triplicate biological replicates of 20 pooled females worms
of the MHco3(ISE), MHco4(WRS), and MHco10(CAVR) strains.
Reads were mapped to the most current version (version 3) of
the MHco3 H. contortus genome assembly (Laing et al., 2013)
using Tophat2 (Kim et al., 2013). The following command
line parameters were used: -I 40000 -r 200 -p 6 -a 6 -g 1 -N 5
–read-gap-length 3 –read-edit-dist 8 –no-discordant –no-mixed –
min-intron 10 –microexon-search –mate-std-dev 40 –library-type
fr-unstranded. A higher allowance for polymorphism between
mapped RNAseq reads and the MHco3 genome assembly was
allowed to ensure reads of other strains were not discarded
due to the numbers of polymorphic sites. Mapped reads were
counted using the htseq-count tool from HTSeq (Anders
and Huber, 2010). DESeq2 was then used to call differential
expression between strains of interest using default settings
(Love et al., 2014). Transcripts that were down-regulated in both
or one resistant strain compared to the susceptible MHco3(ISE)
parental strain were identified. Transcriptomic data can be
accessed via https://data.mendeley.com/datasets/mwvsjgt9jd/
draft?a=2e2cfcc5-589f-4f93-ab6c-9330f92d13e8 (Rezansoff and
Gilleard, unpublished).
Additionally, the top 400 predicted targets of hco-miR-9551
derived from PITA, miRANDA, and RNAhybrid were used in
pathway analysis using DAVID bioinformatics resources (Huang
da et al., 2009). C. elegans orthologs of the predicted H. contortus
genes were identified and used to assemble a gene list which was
entered into the online DAVID tool (https://david.ncifcrf.gov/)
where this list was converted into associated biological pathways
based on gene-annotation enrichment analysis. p values were
adjusted for multiple testing to control the false discovery rate,
using the Benjamini-Hochberg procedure (Anders and Huber,
2010) and pathways with a score of p < 0.05 were considered
significant.
miRNA/mRNA Interactions in HEK293 Cells
3′ UTRs from predicted hco-miR-9551 target genes
HCOI00821400, HCOI00084600, and HCOI01910900 were
amplified from H. contortus genomic DNA, isolated as described
previously (Winter et al., 2013), using PfuUltra II Fusion HS
DNA Polymerase (Agilent) and the following primer sequences
(restriction sites underlined);
HCOI00821400 F Not I 5′GCGGCCGCCGTTGTTCCCATG
CCACTTG-3′
HCOI00821400 R Not I 5′-GCGGCCGCGGATTCAAATCA
GAAGC-3′
HCOI00084600 F Not I 5′-GCGGCCGCGCCCTACAATGT
CTTCGCC-3′
HCOI00084600 R Not I 5′-GCGGCCGCGTGAGCAGGAAA
CAGC-3′
HCOI01910900 F Not I 5′-GCGGCCGCAGATTCAACATC
CTCT-3′
HCOI01910900 R Not I 5′-GCGGCCGCTGATACTGGCTT
TCCTCCA-3′
Products were cloned into pCR2.1-TOPO (Invitrogen) and then
subcloned into the Not I site downstream of firefly luciferase
in pMir-Target (Origene). Similarly, a 298 bp section of the
hco-miR-9551 locus was amplified from H. contortous genomic
DNA using the following primer sequences, mir-9551 F Kpn
I 5′-GGTACCGTTACTTGCCGAT-3′ and mir-9551 R Kpn I
5′-GGTACCTGTCTGTCTCATCA-3′. This product was cloned
into pCR2.1-TOPO and subcloned into vector pEGFP-N1
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(Clontech) using Kpn I to generate plasmids in the forward and
reverse orientation.
HEK293 cells were maintained as described previously
(Winter et al., 2015). For transfections, 1 × 104 cells/ml were
seeded into the wells of 96-well plates in a volume of 100 µl
using Dulbecco’s Modified Eagle’s Medium (containing 4500
mg/L glucose and sodium bicarbonate, Sigma D5671). Cells
were transfected after 24 h when they were ∼50% confluent
using Lipofectamine LTX (Invitrogen) with 50 ng of a mir-9551-
containing plasmid in either the forward or reverse direction,
6.25 ng of the relevant pMir-Target-derived plasmid, and 0.5 ng
of phRG-TK (Renilla luciferase, Promega). Transfections were
performed following the manufacturer’s protocol for HEK293
cells. DNA was diluted to a volume of 20 µL using Opti-MEM I
Reduced SerumMedium (Invitrogen) and 0.35µL Lipofectamine
LTX Reagent added. After incubation at room temperature for
30min 20 µL of the DNA-Lipofectamine complex was then
added directly to the cells in each well. Cells were grown for
48 h then analyzed using a Dual Luciferase Assay kit (Promega)
following the manufacturer’s protocol with six replicates used per
test condition.
RESULTS
A Single miRNA Is Differentially Expressed
in all IVM-Resistant Strains of H. contortus
Analyzed
A microarray consisting of all identified H. contortus miRNAs
(Winter et al., 2012) and all C. elegansmiRNAs (miRBase 15) was
constructed (LC Sciences). The array was probedwith a 1:1mix of
RNA from male and female H. contortus worms recovered from
three individual sheep per strain, yielding triplicate biological
replicates of IVM sensitive strain MHco3(ISE) and IVM resistant
strains MHco4(WRS) and MHco10(CAVR) and the relevant
backcrosses, MHco3/4.BC4 and MHco3/10.BC4 (see section
Materials and Methods for details and nomenclature). The
backcrossed lines have been described previously (Redman et al.,
2012) and had undergone three additional rounds of selection
with IVM when used in the current study. For the four IVM-
resistant strains, worms were also collected from three sheep per
strain that had been treated with 0.2 mg/kg of IVM 7 days prior
to worm collection.
Analysis of the microarray data demonstrated similar
expression levels of most miRNAs between IVM resistant and
sensitive strains. However, a single miRNA, hco-miR-9551,
was found at ∼6-fold greater abundance in the IVM-resistant
parental strains MHco4(WRS) and MHco10(CAVR) compared
to the susceptible parent. In the backcrossed lines, MHco3/4.BC4
and MHco3/10.BC4, hco-miR-9551 was also up-regulated 4-
to 4.5-fold compared to IVM susceptible MHco3(ISE) worms
(p < 0.05 for all samples; see Table 1, Figure 1). No other
miRNA showed the same consistent up-regulation in every IVM-
resistant strain and no miRNA was significantly decreased in all
resistant strains (Figure 2). To investigate whether the expression
of hco-miR-9551 was further induced by exposure to IVM, the
same microarray was probed with RNA isolated from IVM-
resistant worms recovered from sheep that had been treated with
TABLE 1 | Microarray signal for hco-miR-9551 in H. contortus strains.
Isolate hco-miR-9551
signal ± SD
Log2 fold increase
in expression
P-value
MHco3(ISE) 517 ± 185
MHco4(WRS) 3,054 ± 183 2.56 1.50 × 10−2
MHco3/4.BC4 2,475 ± 982 2.26 1.68 × 10
−2
MHco10(CAVR) 3,016 ± 149 2.54 1.51 × 10−2
MHco3/10.BC4 2,081 ± 780 2.01 2.44 × 10
−2
Microarray signal represents mean± SD of three biological replicates. p-value determined
by t-test. Log2 fold increase for all strains is expressed relative to MHco3(ISE) susceptible
strain.
FIGURE 1 | Microarray signal for hco-miR-9551 from triplicate biological
replicates of worms from five different strains. Equal amounts of RNA were
pooled from 20 male and 20 female H. contortus isolated from three individual
animals per strain and were labeled with Cy5 and used to probe the array.
Results are expressed as mean values ± SD.
IVM 7 days previously. No significant difference in hco-miR-9551
expression levels was observed in any of the resistant strains
compared to those recovered from untreated sheep (see Table 2
for details). Thus, hco-miR-9551 does not appear to be further
induced in response to IVM.
qRT-PCR Analysis Confirms That
hco-miR-9551 Expression Is Altered in
IVM-Resistant Worms
As the probes for the array consisted of a mixture of
male and female adult worms, we investigated whether the
expression of hco-miR-9551 varied between sexes and life
cycle stages. Additional RNA samples were prepared in
triplicate from batches of male, female and L3 worms of all
five strains and hco-miR-9551 levels measured by qRT-PCR
relative to hco-miR-50, a constitutively expressed miRNA (see
microarray dataset). The results for female worms broadly
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FIGURE 2 | Microarray Heat Map. Heat maps were generated to depict miRNA expression between groups. Green, under expression; red, overexpression. Data
shown depicts miRNAs showing significantly different levels of expression (p ≤ 0.01) between resistant and susceptible strains of H. contortus using ANOVA which
was applied to produce a miRNA expression profile overview across all samples. *Indicates star strand of miRNAs not in miRBase.
confirmed those from the original microarray; MHco4(WRS)
and MHco10(CAVR) worms showed a 5- to 6-fold increase over
MHco3(ISE) worms, while the backcross lines MHco3/4.BC4
and MHco3/10.BC4 showed ∼a 2- to 3-fold increase in
expression of hco-miR-9551 (Figure 3). In male worms and
L3 larvae, levels of hco-miR-9551 were not significantly
different between susceptible and resistant strains examined
by qRT-PCR (data not shown). The results for these life
cycle stages were much less consistent, reflecting the low
levels of hco-miR-9551 in these stages (see Figure 4A). Thus,
hco-miR-9551 appears to be a miRNA that is significantly
up-regulated in female worms of all IVM-resistant strains tested
in this study.
hco-miR-9551 Is Sex-Linked in MHco3(ISE)
Worms
As qRT-PCR analysis suggested that hco-miR-9551 was highly
expressed in female worms only, we investigated its expression
in greater detail. Data were first analyzed from an identical
microarray that had been probed with samples of RNA isolated
from multiple life cycle stages of MHco3(ISE) worms. These
included L3, in vitro activated L3 (exsheathed and cultured
for 24 h, see section Materials and Methods for detail), L4
recovered at 7 days post-infection, male or female worms, or a
preparation of gut tissue dissected from female worms (Marks
et al. unpublished, but see microarray data set for details).
This analysis confirmed that hco-miR-9551 was expressed in
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female worms of the susceptible MHco3(ISE) strain; male
worms, L3, in vitro activated L3 or gut tissue did not
express significant levels of hco-miR-9551 (see Figure 4A). The
first signs of expression were evident in L4 stages recovered
at 7 days post-infection, suggesting that this miRNA is
developmentally regulated following infection of the mammalian
host.
Expression levels of hco-miR-9551 were confirmed by qRT-
PCR in triplicate biological replicates of male, female and L3
MHco3(ISE) worms. The data in Figure 4B show hco-miR-9551
levels relative to hco-miR-50 and confirm that hco-miR-9551 is
essentially specific to female worms in the MHco3(ISE) strain
with very low levels of expression in male worms or in L3.
TABLE 2 | Microarray signal for hco-miR-9551 in all resistant strains plus/minus
IVM treatment.
Strain ± IVM Mean microarray signal ± SD
MHco4 (WRS) 3,054 ± 183
MHco4 (WRS)+IVM 1,732 ± 256
MHco3/4.BC4 2,475 ± 982
MHco3/4.BC4 + IVM 1,636 ± 340
MHco10 (CAVR) 3,016 ± 149
MHco10 (CAVR)+IVM 2,035 ± 425
MHco3/10.BC4 2,081 ±780
MHco3/10.BC4 + IVM 2,456 ± 732
Microarray signal represents mean ± SD of three biological replicates. p > 0.05 for all
comparisons of ± IVM for any one strain.
FIGURE 3 | Expression of hco-miR-9551 is upregulated in female worms of all
four resistant strains. Graph shows the mean log2 fold increase + SD in
hco-miR-9551 levels in female worms of four IVM-resistant strains relative to
the MHco3(ISE) susceptible strain, quantitated by RT-PCR. Triplicate biological
samples of female worm RNA were analyzed for each strain. Data were
normalized to expression levels of hco-miR-50 and levels of hco-miR-9551
expressed in resistant worms relative to that in MHco3(ISE). MxPro data were
analyzed to ensure equal efficiency of reactions using Lin-Reg® followed by
REST2009®. Results are presented using the corrected data.
To determine if hco-miR-9551 is expressed in eggs developing
within adult female worms, further qRT-PCR studies were
carried out. No detectable signal was observed for hco-miR-9551
in a pool of eggs/L1 larvae collected from in vitro culture,
nor was it detected in gut tissue isolated from single adult
females, while a control miRNA could be amplified from
all samples (data not shown). However, hco-miR-9551 was
identified in a small RNA library prepared from excretory-
secretory (ES) products of adult MHco3(ISE) worms and could
FIGURE 4 | (A) hco-miR-9551 is developmentally regulated in MHco3(ISE)
worms. Signal from microarray probed with triplicate samples of different life
cycle stages of MHco3(ISE) H. contortus. Graph shows the signal ± SD for
hco-miR-9551 in blue and a constitutively expressed miRNA, hco-miR-50 in
red. In this array, RNA was labeled with Cy3. (B) Expression profile of
hco-miR-9551 by qRT-PCR. qRT-PCR of MHco3(ISE) life cycle stages using
triplicate biological replicates of L3, adult males or adult female worms. Graph
shows the log2 fold increase over L3 normalized to hco-miR-50. MxPro data
were analyzed to ensure equal efficiency of reactions using Lin-Reg® followed
by REST2009®. Results are presented using the corrected data.
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be amplified by PCR from ES products of cultured adult
worms of both backcrosses (Gu et al. unpublished data),
suggesting it may be released from the secretory system and/or
female gonad.
Characterisation of the hco-miR-9551
Locus
The hco-miR-9551 locus is located on scaffold_496 (Laing
et al., 2013) and see WormBase ParaSite (http://parasite.
wormbase.org). This scaffold is just over 140Kb in length
and encodes eight protein-coding gene models. Five of these
gene models have predicted orthologs in C. elegans, all of
which reside on the X chromosome, suggesting scaffold_496
is derived from the H. contortus X chromosome. All eight
gene models are encoded on the reverse strand, while the
hco-miR-9551 precursor sequence is encoded on the forward
strand, lying 3,866 bp downstream (3′ end) of gene model
HCOI01030600.t1 and 10,152 bp upstream (5′ end) of gene
model HCOI01030500.t1 (See scaffold in Figure S1). Evidence
in the literature has shown that that some miRNAs can
affect the expression of genes in close proximity, providing
a local negative feedback mechanism (van Rooij et al., 2009;
Dill et al., 2012; Truscott et al., 2014; Yuva-Aydemir et al.,
2015) and interestingly, both these genes are expressed at a
lower level in MHco4(WRS) and MHco10(CAVR) than in
MHco3(ISE) female worms, although the differences do not
reach significance (data not shown). Searching for hco-miR-9551
binding sites in both genes demonstrated that HCOI01030600.t1
contained four potential sites in the 3′ UTR and one within
the open reading frame. The predicted products of these
genes are of unknown function and they have no conserved
domains or orthologs in C. elegans. They do, however, have
orthologs in other clade V parasitic nematodes including
Oesophagostomum dentatum and Ancylostoma ceylanicum
(for HCOI01030600.t1) and A. ceylanicum and Dictyocaulus
viviparus (for HCOI01030500.t1).
miR-9551 Is Specific to Clade V Parasitic
Nematodes
There are no orthologs of hco-miR-9551 documented in
miRBase, but scrutiny of the genomes of other clade V
parasitic species identified an orthologous sequence in several
species. In each case, RNA-fold analysis of the parasite mir-
9551 using Mfold (http://unafold.rna.albany.edu/?q$=$mfold/
RNA-Folding-Form) (Zuker, 2003), supports a hairpin structure
with folding energies consistent with miRNA structure (data
shown in Table S2). No such sequence was found in free-living
nematodes, such as Caenorhabditis species and examination of
parasitic nematode sequences from species belonging to clade
I, III or IV, failed to identify any orthologs of hco-miR-9551.
Thus, hco-miR-9551 appears to be specific to clade V parasitic
nematodes belonging to the sub-order Strongylida. The only
miRNA present in miRBase showing any degree of homology
with hco-miR-9551 is miR-308-3p from various species of
Drosophila, which shares the same seed sequence (nucleotides
2-7) with hco-miR-9551.
FIGURE 5 | Expression of miR-9551 is upregulated in resistant
T. circumcincta. Triplicate biological samples of MTci2 and MTci5 adult female
worms (susceptible and resistant, respectively) were analyzed by qRT-PCR for
changes in the expression levels of tci-miR-9551. Graph shows the log2 fold
increase of tci-miR-9551 normalized to tci-miR-50. As above, efficiency of the
reactions were analyzed using Lin-Reg® followed by REST2009® and results
are presented using the corrected data.
miR-9551 Is Also Upregulated in
Multi-Drug Resistant T. circumcincta
To investigate whether upregulation of miR-9551 occurred in
other parasitic nematodes showing resistance to IVM, we focused
on the related strongylid T. circumcincta. Strain MTci2 is
susceptible to anthelmintic, while strain MTci5 shows resistance
to IVM, fenbendazole and levamisole (Dicker et al., 2011).
Expression levels of the T. circumcincta hco-miR-9551 ortholog,
tci-miR-9551,were compared in the drug sensitive strain (MTci2)
compared to the multi-drug resistant strain (MTci5). As can be
seen from Figure 5, the expression of tci-miR-9551 was 16-fold
higher in drug resistant T. circumcinta (p= 0.037).
Identifying mRNA Targets of hco-miR-9551
Using Bioinformatic and Comparative
Genomic Approaches
Determining the function of a specific miRNA is difficult, even
in organisms such as C. elegans, where genetic manipulation
is feasible. In an attempt to define the biological roles of
hco-miR-9551, we identified target mRNAs using computational
programmes that search for miRNA binding sites. We screened
an in silico 3′ UTR library using three separate programmes,
miRANDA, PITA, and RNAhybrid to increase the likelihood
of identifying true mRNA targets (see section Materials and
Methods for details of settings). Only those 3′ UTRs scoring
positive in all three programmes were considered further. The
number of 3′ UTRs containing predicted hco-miR-9551 binding
sites varied markedly from 2,255 using MIRANDA to 653 and
435 with RNAhybrid and PITA, respectively. In all, 73 UTRs
were predicted by all three programmes to have hco-miR-9551
binding sites, of which 68 had overlapping binding sites predicted
by all three programmes and therefore were considered “high
confidence” targets (data shown in Table S3).
As miRNA expression frequently shows an inverse correlation
with target mRNAs, we aimed to narrow down potential mRNA
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targets for further analysis, by scrutinizing a transcriptomic
dataset prepared from adult female worms of the MHco3(ISE),
MHco4(WRS) and MHco10(CAVR) strains (Rezsanoff, Laing
and Gilleard, unpublished). Of the 26,064 genes in this
transcriptomic dataset, a total of 694 were down-regulated
in both MHc04(WRS) and MHc010(CAVR) female worms
compared to MHc03(ISE). We focused on the expression profile
of the 68 genes with predicted hco-miR-9551 binding sites
in both resistant strains, MHc04(WRS) and MHc010(CAVR),
compared to the susceptible strain, MHco3(ISE). Of these
68 genes, three showed significantly reduced expression in
both resistant strains (Benjamini-Hochberg adjusted score
p < 0.05) as listed in Table 3A. The expression of several
other mRNAs was reduced in only one of the resistant
strains compared to the IVM-susceptible female worms (see
Table 3B). Of the three genes down-regulated in both resistant
strains, HCOI00084600 is a predicted RNA-binding protein in
both H. contortus and C. elegans, HCOI00821400 contains a
ChaC domain with predicted gamma-glutamyl cyclotransferase
(GGCT) function, while HCOI01910900 encodes a hypothetical
protein. Two genes were significantly down-regulated only
in MHco4(WRS) worms; these encoded a predicted protein
with a 7-transmembrane G-protein-coupled receptor domain
(HCOI00499800), the C. elegans homolog of which (ser-
4) shows similarity to mammalian serotonin receptors. The
TABLE 3A | Predicted mRNA targets of hco-miR-9551 down-regulated in both
IVM-resistant strains, MHco4(WRS), and MHco10(CAVR) compared to the
susceptible MHco3(ISE) strain.
mRNA HCOI00084600 HCOI01910900 HCOI00821400
Predicted protein RNA recognition motif Hypothetical ChaC domain
Normalized Expression
MHco3(ISE)
243.64 9.39 37.51
Normalized Expression
MHco4(WRS)
68.037 1.367 18.23
Log2 fold change −1.84 −2.78 −1.04
Adjusted P value 0.001 0 0.044
Normalized Expression
MHco10(CAVR)
47.625 2.302 14.638
Log2 fold change −2.355 −2.028 −1.358
Adjusted P-value 0 0 0.006
second gene is a probable vacuolar ATPase (HCOI01954200).
In MHco10(CAVR) worms, a collagen gene (HCOI02065400),
a probable histone acetyltransferase gene (HCOI00706800)
and a protein with a predicted glycolipid-transfer domain
(HCOI0277200) were all significantly down-regulated. The
putative C. elegans homologs of these genes and their RNAi
phenotypes are shown in Tables 4A and B.
As the analysis described above relied upon the relatively
stringent requirement for each mRNA target to be recognized
by all three programmes, genes of interest could potentially
be excluded. We addressed this issue by adopting a broader,
overall view of the predicted targets to identify pathways
enriched in the target gene data. The top 400 hits were
selected from each of the three target prediction programmes,
their orthologs identified in C. elegans and analyzed using
the DAVID bioinformatic database. Allowing for genes that
appeared in two or more lists and those which did not have
orthologs in C. elegans, 485 WormBase identifiers were used
to create a gene list, which was entered into the DAVID
online tool. Functional annotation clusters were generated
and significant pathways identified (Benjamini-Hochberg
adjusted score p < 0.05, see Figure 6). Individual genes in each
pathway are outlined in Table S4. Importantly, these included
membrane/transmembrane associated genes, lipoproteins,
metal-binding genes and transport-associated genes. Although
P-glycoproteins are the classical drug transporters in nematodes
and have been associated with drug resistance (Kerboeuf and
Guegnard, 2011; Choi et al., 2017), these were not identified in
the DAVID pathway analysis, suggesting involvement of a novel
mechanism of resistance.
Confirming Predicted hco-miR-9551
Interactions
Three predicted hco-miR-9551/mRNA interactions from the
transcriptomic analysis were further investigated by transfection
of HEK293 cells in a dual luciferase assay. 3′ UTRs of
HCOI00821400, HCOI00084600, and HCOI01910900 from
H. contortus were cloned downstream of firefly luciferase and
transiently transfected into HEK293 cells along with a plasmid
containing hco-miR-9551 in the forward or reverse direction. The
CHAC-domain containing protein HCOI00821400 contained
two putative hco-miR-9551 binding sites in the 3′ UTR, while
HCOI00084600 and HCOI01910900 contain one. This was
TABLE 3B | Genes down regulated in one resistant strain only vs. MHco3(ISE).
mRNA HCOI02065400 HCOI00706800 HCOI02177200 HCOI01954200 HCOI00499800
Predicted protein Collagen MOZ SAS containing WD-40 repeat-like domain ATPase domain 7 TM GPCR domain
Normalized expression MHco3(ISE) 48.3 131.55 133.42 368.48 21.84
Normalized expression MHco4(WRS) 35.6 105.816 178.11 115.2 10.97
Log2 fold change −0.44 −0.314 −0.177 −1.677 −0.994
Adjusted P-value 0.144 0.335 0.413 0 0.023
Normalized expression MHco10(CAVR) 21.476 70.421 88.76 281.73 14.45
Log2 fold change −1.169 −0.902 −0.594 −0.387 −0.595
Adjusted P-value 0 0.002 0.001 0.343 0.188
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TABLE 4A | C. elegans homologs and RNAi phenotypes of genes down-regulated in both resistant strains.
Hco gene C. elegans homolog Predicted protein Function RNAi phenotype
HCOI00084600 R06C1.4 Ortholog of human CSTF2 (Cleavage
stimulation factor, 3′ pre-RNA, sub-unit 2)
Nucleic acid binding; embryonic
development
None
HCOI01910900 None
HCOI00821400 F22F7.7 Ortholog of human CHAC1
(gamma-glutamyl cyclotransferase)
Located to striated muscle- structural None
TABLE 4B | C. elegans homologs and RNAi phenotypes of genes down-regulated in one resistant strain only.
Hco gene C. elegans homolog Predicted protein Function RNAi/mutant phenotype
HCOI02065400 M110.1 (col-76) Collagen Cuticle Unknown
HCOI00706800 R07B5.9 (lsy-12) Histone acetyltransferase DNA binding; required for neuronal
differentiation; gonad formation,
locomotion, etc.
Bagging, sick, protruding vulva,
egg-laying defects
HCOI02177200 F49D11.10 Ortholog of human glycolipid transfer
domain; WD repeat protein 75
Unknown Unknown
HCOI01954200 F49C12.13 (vha-17) Ortholog of vacuolar proton-translocating
ATPase
Proton transport; embryo
development, syncytial fusion, body
morphogenesis. Localized to gut cells,
gut granules, hypodermis
Apoptosis increased/ variant;
embryonic lethal etc.
HCOI00499800 Y22D7AR (ser-4) Ortholog of mammalian 5-HT1 serotonin
receptor
Signal transduction; lifespan; negative
regulator of locomotion; egg-laying
hyperactive, amplitude of sinusoidal
movement variant, extended life span
FIGURE 6 | Target gene pathway analysis. C. elegans homologs of predicted hco-miR-9551 targets were entered into DAVID Bioinformatics Database. Those
significantly enriched are shown above. Statistically significant target gene pathways identified by DAVID (Benjamini-Hochberg score p < 0.05).
determined using the PITA algorithm (Kertesz et al., 2007) using
a minimum seed size of 8, allowing for a single G:U wobble and
a single mismatch and results were refined by considering only
those with PITA11G energies of<−7 (see Table 5).
Levels of luciferase in the presence of the forward or reverse
hco-miR-9551 were compared. The 3′ UTR of HCOI00821400
showed a small (10.5%) but highly significant reduction
(p = 1.9E-5) in expression in the presence of the forward
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TABLE 5 | High confidence hco-miR-9551 target sites determined using PITA
algorithim.
Gene Position Seed 1Gduplex 1Gopen 11G
HCOI00821400 638 8:0:1 −20 −5.89 −14.10
HCOI00821400 41 8:0:1 −15.9 −8.89 −7.00
HCOI00084600 481 8:1:0 −21.7 −10.69 −11.00
HCOI01910900 162 8:0:0 −20 −8.08 −11.91
FIGURE 7 | hco-miR-9551 interacts with predicted target gene
HCOI00821400 (CHAC-domain containing) 3′ UTR. Graph shows the
repression of firefly luciferase in HEK293 cells transfected with the 3′ UTR of
predicted target mRNA, HCOI00821400, but not with the 3′ UTR of
HCOI00084600 or HCOI01910900. Data expressed as the mean ratio, ±
standard deviation of three experiments comparing Firefly to Renilla luciferase
signal in the presence of hco-miR-9551 cloned in the forward orientation
relative to the negative control (hco-miR-9551 cloned in the reverse
orientation) where the reverse is expressed as 1. hco-miR-9551 and the 3′
UTR of HCOI00821400 resulted in a significant reduction in signal (p = 1.9E-5
t test). *p < 0.05.
hco-miR-9551, while there was no difference in expression for
the 3′ UTRs of HCOI00084600 and HCOI01910900 when cells
were transfected with the forward or reverse hco-miR-9551.The
mean of three experiments comparing expression in the presence
of the forward hco-miR-9551 relative to the reverse is shown in
Figure 7.
DISCUSSION
Understanding the mechanisms by which parasites develop
drug resistance is important for improved diagnosis and for
monitoring the spread of resistant alleles. While most studies
on IVM resistance have focused on identifying mutations in
presumed target sites, differences in the levels of expression
of resistance-related genes have been observed. In this study,
we investigated whether IVM resistance was associated with
alterations in the expression of regulatory RNAs that could
influence gene expression, as reported in some tumor cell
models of drug resistance (Adam et al., 2009; Ahmad et al.,
2015; Abdi et al., 2016). By microarray analysis, a single
miRNA, hco-miR-9551, was found to be differentially expressed
in all four IVM resistant strains compared to susceptible
worms. This miRNA was most abundant in the two parental
strains, MHco4(WRS) and MHco10(CAVR), and was also
significantly upregulated in the backcross lines, MHco3/4.BC4
andMHco3/10.BC4. The IVM-resistant strains used in this study,
MHco3(WRS) and MHco10(CAVR) derive from geographically
distinct areas (South Africa and Australia, respectively) and are
genetically divergent from each other. Consequently, one would
predict that resistance in the two strains might have originated
independently. The results obtained with both backcrosses
are particularly compelling, as current estimates suggest that
between 5 and 10% of the genome of the resistant parent
is introgressed into the respective backcross (Rezansoff and
Gilleard, unpublished). While the hco-miR-9551 locus does not
appear to be physically linked to a major introgressed region
identified so far, we cannot rule out the possibility that it may be
linked with shorter, as yet unidentified, introgressed sequences.
hco-miR-9551 appears to be restricted to clade V parasitic
nematodes, a group containing many important pathogens of
humans and animals in which anthelmintic resistance is widely
observed. Importantly,miR-9551 is also significantly upregulated
in anthelmintic resistant T. circumcincta, the most prevalent
parasitic nematode in UK sheep, in which multi-drug resistance
is a major problem (Sargison et al., 2007). Taken together
these data show that miR-9551 expression is correlated with an
anthelmintic resistance phenotype in two important parasitic
nematodes.
Over 80% of one-to-one orthologs in H. contortus and
C. elegans occur on the same chromosome (Laing et al., 2013)
and by analogy with gene content in C. elegans, hco-miR-9551
is predicted to reside on the X chromosome of H. contortus. A
recent study demonstrated that in nematodes, the X chromosome
is enriched for genes with female-biased expression (Albritton
et al., 2014). In keeping with this finding, the expression of
hco-miR-9551 is enriched in female worms of the susceptible
MHco3(ISE) isolate, as confirmed by analysis of different
life cycle stages by microarray and qRT-PCR. Analysis of
hco-miR-9551 expression in male worms and L3 in all strains
produced inconsistent results, likely related to the very low
level of expression of hco-miR-9551 in these stages. Sex-linked
difference in susceptibility to IVM have been reported previously
with female MHco10(CAVR) worms being more resistant than
males (Le Jambre et al., 1995), but other non-sex-linked factors
also play a role in drug resistance. The only other miRNA with
significant homology to hco-miR-9551 isDrosophila melanogaster
miR-308; a previous study showed that inhibition of this
miRNA was associated with increased levels of apoptosis in
embryos via de-repression of pro-apoptotic factors (Leaman
et al., 2005). Whether the up-regulation of hco-miR-9551 may
have a similar embryo-protective role in the face of IVM
exposure remains to be determined, but this could explain
its sex-specific expression profile. In addition to its paralyzing
effect on worms, IVM also affects embryogenesis in nematodes
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(Scott et al., 1991; Chavasse et al., 1992), but the precise
mechanisms by which this effect is mediated remain largely
unresolved.
Identifying differentially regulated miRNAs is only part of
the story: understanding the potential role of miRNAs in
drug resistance requires identification of the mRNA targets.
We identified possible hco-miR-9551 targets from a searchable
database of predicted 3′ UTR sequences. Although it is now
appreciated that miRNAs can bind elsewhere in a gene, including
at sites in the open reading frame or 5′UTR (Zisoulis et al.,
2010), the best-characterized binding sites are those in the 3′
UTR. To narrow down the large number of “hits,” we applied
three separate programmes, each of which use different search
parameters, and focused only on genes that were identified
by all three and that had predicted overlapping binding sites
in the 3′ UTR. 68 “high confidence” genes were identified in
common among the three lists of putative targets significantly
more than would be expected by chance (p < 0.001, Chi-
square test). The expression of these 68 genes was then
further analyzed using transcriptomic data from the susceptible,
MHco3(ISE) and resistant parental strains, MHco4(WRS) and
MHco10(CAVR) resulting in the identification of several genes
containing hco-miR-9551 binding sites that were down-regulated
in the resistant strains.
Of the three genes down-regulated in both resistant strains
one encoded a protein with a RNA recognition domain which, by
analogy withC. elegans, is likely to be involved in polyadenylation
of mRNA. The mammalian homolog, CSTF2, binds to GU
rich elements in the 3′ UTR of mRNA and is reported to
be over-expressed in some tumors (Deka et al., 2005). Of the
other predicted targets of hco-miR-9551 down-regulated in both
resistant strains, one encodes a hypothetical protein and the
other, a CHAC protein domain-containing protein. CHAC1 has
gamma-glutamyl cyclotransferase (GGCT) activity, catalyzing
the cleavage of glutathione to 5-oxy-proline and free amino
acids. Down regulation of GGCT activity has previously been
implicated in drug resistance in an adriamycin-resistant breast
cancer cell line MCF-7 (MFC-7/ADR). In that study it was
proposed that decreased activity of GGCT is necessary for MCF-
7/ADR cells to maintain a high level of glutathione, which in turn
exports adriamycin out of the cell (Wang et al., 2015). Conversely,
when over expressed, CHAC1 can lead to the intracellular
depletion of glutathione and the initiation of apoptosis (Wagstaff
et al., 2012). The H. contortus CHAC1 is predicted to have a
conserved GGCT domain and a reduction in CHAC1 protein
could result in a tissue-specific increase in glutathione levels
that may enhance detoxification pathways or protect against
apoptosis by maintaining glutathione levels in drug resistant
worms. Resistance can be manifest in multiple ways, other than
direct effects on adult worm survival; for example, mechanisms
that enhance embryo survival may also contribute to a resistance
phenotype and may explain the female specific expression of
hco-miR-9551. Interestingly, of the three genes down-regulated
in resistant worms and predicted to be targets of hco-miR-9551,
only chac-1 is located on a scaffold likely to be within a region
introgressed into the MHco3(ISE) genome from the resistant
parents (Rezansoff and Gilleard, unpublished) and, significantly,
this was the only 3′ UTR of three tested that showed an
interaction with hco-miR-9551 in the dual luciferase assay.
Of the genes down-regulated only in the MHco10(CAVR)
IVM resistant strain, one is a predicted histone acetyltransferase.
The C. elegans homolog of this gene, lsy-12, is important
for neuronal differentiation and gonad formation. lsy-12
mutant worms display a range of additional defects, including
abnormalities in locomotion, egg-laying, and fecundity
(Sarin et al., 2007, 2008). Other genes down-regulated in
MHco10(CAVR) worms include a protein related to a human
glycolipid transfer protein GLTPD2, which containsWD repeats,
a type of protein that can be involved in pre-RNA processing.
The two genes significantly down-regulated in MHco4(WRS)
worms encode a vacuolar ATPase, which in C. elegans, is required
for viability. vha-17 is expressed in embryonic gut cells and is
regulated by pgp-2, a member of the multi-drug resistance
family of p-glycoproteins (Schroeder et al., 2007). The final gene
encodes a protein with a predicted 7-transmembrane GPCR
domain. The C. elegans homolog is ser-4, a mammalian serotonin
receptor ortholog, which is expressed in a variety of neurons in
the free-living worm (Tsalik et al., 2003).
While miR-9551 was upregulated 6-fold in IVM-resistant
H. contortus and up to 16-fold in resistant T. circumcincta it
is difficult to predict the significance of these changes in a
multicellular organism without additional information on where
the miRNA is expressed within the worm, the number of
potential mRNA targets, their expression levels and the strength
of the interaction between miRNA and mRNA. However, much
of the work on the role of miRNA in drug resistance has been
carried out in tumor cells where there are many examples of
miRNA expression changes of similar magnitude being involved
in, or directly responsible for, chemoresistance (reviewed in
Magee et al., 2015).
miRNAs frequently regulate genes within networks and
so, in addition to identifying individual genes that may be
targeted by hco-miR-9551 to alter drug susceptibility, we
also used pathway analysis to identify enrichment of specific
functional networks. The major pathways included transport
and membrane/transmembrane associated genes. In view of
the hydrophobic nature of IVM, changes in the expression of
receptors and channels involved in uptake and efflux of the
drug across cell membranes are clearly relevant to resistance.
Alternatively, we cannot rule out that hco-miR-9551 upregulation
is an indirect consequence of resistance, perhaps rebalancing
membrane or transport networks responsible for resistance;
these hypotheses will require further investigation. Nevertheless,
our finding that a single miRNA is upregulated in the two
parental and two backcrossed resistant lines of H. contortus,
which originate from different geographical locations, as well
as in resistant T. circumcincta, identifies a potentially novel
mechanism of drug resistance in nematodes and contributes to
understanding mechanisms of IVM resistance. These findings
also have relevance in determining whether levels of resistance
could be modulated and whether hco-miR-9551 may represent a
putative biomarker of IVM resistance in parasitic nematodes.
In conclusion, our study provides a novel paradigm by
demonstrating that a regulatory RNA may play a role in this
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important phenomenon. While mutations in the targets of IVM,
such as the GluCls, have been identified inmany previous studies,
other regulatory factors have not been examined. Non-coding
RNAs are gaining prominence in other systems, both as drug
targets and as mediators of resistance (Howe et al., 2015). As
anthelmintic resistance continues its inexorable spread, looking
beyond the protein targets of drugs to the regulatory mechanisms
that influence resistance phenotypes could bear fruit.
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